Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis

Published:2022-11-02 Issue:1 Volume:57 Page:23-36
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Bogatic Damjana¹²^ORCID,Bryant Robert V.¹²,Lynch Kate D.²³,Costello Samuel P.¹²^ORCID

Affiliation:

1. Department of Gastroenterology The Queen Elizabeth Hospital Woodville South Australia Australia

2. Faculty of Health Sciences School of Medicine University of Adelaide Adelaide South Australia Australia

3. IBD Service Department of Gastroenterology and Hepatology Royal Adelaide Hospital Adelaide South Australia Australia

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17251

Reference79 articles.

1. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

2. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

3. Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence;Mertz A;Ann Gastroenterol,2019

4. Bile acids for primary sclerosing cholangitis;Poropat G;Cochrane Database Syst Rev,2011

5. Urosdeoxycholic acid in primary sclerosing cholangitis: A meta-analysis and systematic review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter: Microbial manipulation for primary sclerosing cholangitis‐associated inflammatory bowel disease—hope on the horizon;Alimentary Pharmacology & Therapeutics;2024-07-16

2. Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease?;Alimentary Pharmacology & Therapeutics;2024-04-23

3. Coexisting Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Overlapping Challenges in Diagnosis and Treatment;Case Reports in Gastroenterology;2024-03-26

4. The microbiome landscape in pediatric Crohn’s disease and therapeutic implications;Gut Microbes;2023-08-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3